Formosa Pharmaceuticals (TPE:6838) Total Liabilities : NT$563.7 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Formosa Pharmaceuticals Total Liabilities?

Formosa Pharmaceuticals's Total Liabilities for the quarter that ended in Dec. 2024 was NT$563.7 Mil.

Formosa Pharmaceuticals's quarterly Total Liabilities increased from Jun. 2024 (NT$512.92 Mil) to Sep. 2024 (NT$545.58 Mil) and increased from Sep. 2024 (NT$545.58 Mil) to Dec. 2024 (NT$563.70 Mil).

Formosa Pharmaceuticals's annual Total Liabilities increased from Dec. 2022 (NT$410.51 Mil) to Dec. 2023 (NT$586.21 Mil) but then declined from Dec. 2023 (NT$586.21 Mil) to Dec. 2024 (NT$563.70 Mil).

Formosa Pharmaceuticals Total Liabilities Historical Data

The historical data trend for Formosa Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Formosa Pharmaceuticals Total Liabilities Chart

Formosa Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

261.93

295.48

410.51

586.21

563.70

Formosa Pharmaceuticals Quarterly Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial										586.21	631.44	512.92	545.58	563.70

Formosa Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Formosa Pharmaceuticals's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	197.951	+	(20.304	+	345.445
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	563.7

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	2112.272	-	1548.572
	=	563.7

Formosa Pharmaceuticals's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	197.951	+	(20.304	+	345.445
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	563.7

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	2112.272	-	1548.572
	=	563.7

Formosa Pharmaceuticals Total Liabilities Related Terms

Thank you for viewing the detailed overview of Formosa Pharmaceuticals's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Formosa Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Formosa Pharmaceuticals Inc (TPE:6838) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 57, Fuxing North Road, 8th Floor 6, Songshan District, Taipei, TWN, 105

Website

https://www.formosapharma.com

Formosa Pharmaceuticals Inc. is a late-preclinical and early-clinical-stage biopharmaceutical company with a focus on the indications of ophthalmology, oncology, and anti-infectives.

Formosa Pharmaceuticals Headlines

No Headlines